Seelos Therapeutics Insider Trades

SEEL

Track insider trading activity from Seelos Therapeutics executives and directors. See which insiders are buying and selling SEEL stock.

Trades Last 12 Months

SEEL Price

All Insider Trades for Seelos Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Golembiewski Michael Joseph Chief Financial Officer
Holding Value $32.1k 86,869 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.9k 417 shares
$165.12
$0.37
Mehra Raj See Remarks
Holding Value $26k 70,383 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7M 70,383 shares
$180.48
$0.37
Holding Value $616 1,666 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 1,666 shares
$170.24
$0.37
Lian Brian Director
Holding Value $616 1,666 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 1,666 shares
$170.24
$0.37
Pascoe Richard W Director
Holding Value $616 1,666 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 1,666 shares
$170.24
$0.37
Holding Value $616 1,666 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 1,666 shares
$170.24
$0.37
Dunn Judith Director
Holding Value $5.92k 16,000 shares
Last Trade
Jan 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83M 16,000 shares
$5,189.18
$0.37
Smith Robin L Director
Holding Value $5.92k 16,000 shares
Last Trade
Jan 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.3M 16,000 shares
$5,458.25
$0.37
Holding Value $0 0 shares
Last Trade
Mar 24, 2019 Sale
$34.3B 3,450,000 shares
$9,955.55
$0.37
Morton Neil Svp, Chief Business Officer
Holding Value $37.1k 100,158 shares
Last Trade
Jan 23, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$831M 32,705 shares
$25,406.26
$0.37
Holding Value $42.9k 115,891 shares
Last Trade
Aug 30, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.65B 43,225 shares
$38,092.07
$0.37
Denner Alexander J 10% owner
Holding Value $0 0 shares
Last Trade
Mar 21, 2018 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$53.6B 653,409 shares
$81,955.67
$0.37
Holding Value $18.5k 50,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2B 50,000 shares
$243,558.39
$0.37
Maier Paul V Director
Holding Value $13k 35,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.52B 35,000 shares
$243,558.39
$0.37
Ray Rusty Director
Holding Value $13k 35,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.52B 35,000 shares
$243,558.39
$0.37
Smith Sandford D Director
Holding Value $13k 35,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.52B 35,000 shares
$243,558.39
$0.37
Wierenga Wendall Director
Holding Value $13k 35,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.52B 35,000 shares
$243,558.39
$0.37
Bovenizer Catherine VP Finance & CAO
Holding Value $12.8k 34,594 shares
Last Trade
May 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2B 50,000 shares
$444,407.48
$0.37
Troupin Barbara Svp, Chief Medical Officer
Holding Value $74k 200,000 shares
Last Trade
Mar 15, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$256B 200,000 shares
$1,281,278.72
$0.37
Holding Value $9.25k 25,000 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28B 25,000 shares
$1,119,676.00
$0.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up